Forget Anthropic: Biotech is quietly dominating the IPO sphere
Photo: Barron's
As investors wait for the Claude developer to file its official IPO paperwork, several biotechs are going public and doing just fine.
First reported by Barron's. This page is a short excerpt; the full text is theirs.
Read the full story at Barron's
